PharmaBoardroom

Louis Cheng – CEO, Leadgene Biomedical, Taiwan

Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody technologies, his ambitious…

Michael Chan – Senior Vice President, Global Issuer…

Michael Chan, Senior Vice President of Global Issuer Services for the Hong Kong Exchange (HKEX) highlights the vibrancy and diversity that biotechs…

UK Pharma News Roundup May 2020

Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British intensive care units (ICUs),…

Pharma Faces: Carol Lynch, Sandoz US

Carol Lynch, president of Sandoz US and head of Sandoz North America, recently spoke exclusively to PharmaBoardroom about how her diverse global…

Chinese Biotechs’ Domestic Pricing Strategies

Alphamab Oncology and I-Mab Biopharma, two of China’s fastest-growing biotech firms, both bolstered by recent successful IPOs, are increasingly…

Chae-Ok Yun – Founder, CEO & CTO, GeneMedicine

Founder, CEO and CTO Dr Chae-Ok Yun introduces GeneMedicine, a pioneer of the oncolytic virus approach in gene therapy. Dr Yun outlines the…

Xu Ting – Founder, Chairman & CEO, Alphamab Oncology,…

PharmaBoardroom caught up with Alphamab Oncology’s founder, chairman and CEO Dr Xu Ting again 16 months after our last interview to hear about their…

Carol Lynch – President, Sandoz US; Head, Sandoz North…

Carol Lynch of Sandoz US talks candidly on the US generics market from an international perspective, market access, biosimilars uptake, talent…

Johnsee Lee – Chairman, Taiwan Bio Industry Organization;…

Taiwan Bio Industry Organization Chairman Dr Johnsee Lee outlines the Taiwanese biopharmaceutical industry’s rapid and coordinated response to the…

Worried About Biogen’s Aducanumab? Don’t Be

Dr Neil Cashman examines the recent news around Biogen's Alzheimer's treatment aducanumab, assuages some investor fears, and underlines the…

China Pharma News Roundup May 4th 2020

A selection of recent big stories from Chinese pharma, including Novo Nordisk's updated China strategy, Chinese biotechs' funding successes, and some…

Hot Topics in US Healthcare & Pharma

So far in 2020 PharmaBoardroom has conducted interviews with several key stakeholders in US healthcare. We have heard from leaders the US FDA, as well…

Tagged with BIO